candida

  1. R

    diaphragm pacemaker article

    Neural Signals Executive Comments on Market for Phrenic Nerve Stimulation Philip Kennedy, president of Neural Signals, Inc. and a pioneer in cortical control of neural prostheses, comments on NBR editor James Cavuoto’s publisher’s letter “A Breath of Fresh Air,” published in the March 2003...
  2. P

    CytRx Phase II Trial for ALS - arimoclomol

    CytRx Phase II Trial for ALS (Lou Gehrig's Disease) Expected to Begin After Second Quarter Monday June 20, 8:30 am ET Company responds to FDA request for information regarding arimoclomol CytRx Corporation (Nasdaq: CYTR - News), a biopharmaceutical company engaged in the development and...
    • PALS Mike
    • Thread
    • ability als brain candida clinical clinical trial diagnosis documents familial fda food information lou gehrig's disease medical movement muscles neurology professor research robert sod1 testing treatment trial worldwide
    • Replies: 0
    • Forum: Research and trials
Back
Top